Journal of Multimorbidity and Comorbidity (Dec 2022)

The DynAIRx Project Protocol: Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity

  • Lauren E Walker,
  • Aseel S Abuzour,
  • Danushka Bollegala,
  • Andrew Clegg,
  • Mark Gabbay,
  • Alan Griffiths,
  • Cecil Kullu,
  • Gary Leeming,
  • Frances S Mair,
  • Simon Maskell,
  • Samuel Relton,
  • Roy A Ruddle,
  • Eduard Shantsila,
  • Matthew Sperrin,
  • Tjeerd Van Staa,
  • Alan Woodall,
  • Iain Buchan

DOI
https://doi.org/10.1177/26335565221145493
Journal volume & issue
Vol. 12

Abstract

Read online

Background Structured Medication Reviews (SMRs) are intended to help deliver the NHS Long Term Plan for medicines optimisation in people living with multiple long-term conditions and polypharmacy. It is challenging to gather the information needed for these reviews due to poor integration of health records across providers and there is little guidance on how to identify those patients most urgently requiring review. Objective To extract information from scattered clinical records on how health and medications change over time, apply interpretable artificial intelligence (AI) approaches to predict risks of poor outcomes and overlay this information on care records to inform SMRs. We will pilot this approach in primary care prescribing audit and feedback systems, and co-design future medicines optimisation decision support systems. Design DynAIRx will target potentially problematic polypharmacy in three key multimorbidity groups, namely, people with (a) mental and physical health problems, (b) four or more long-term conditions taking ten or more drugs and (c) older age and frailty. Structured clinical data will be drawn from integrated care records (general practice, hospital, and social care) covering an ∼11m population supplemented with Natural Language Processing (NLP) of unstructured clinical text. AI systems will be trained to identify patterns of conditions, medications, tests, and clinical contacts preceding adverse events in order to identify individuals who might benefit most from an SMR. Discussion By implementing and evaluating an AI-augmented visualisation of care records in an existing prescribing audit and feedback system we will create a learning system for medicines optimisation, co-designed throughout with end-users and patients.